Raphael Pharmaceutical Inc. (RAPH)
Raphael Pharmaceutical Inc. (RAPH)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 1 | 45 | 3 | NaN |
| Other current assets | NaN | 6 | 2 | 8 |
| Cash and cash equivalents | NaN | NaN | NaN | 20 |
| Total current assets | 1 | 51 | 5 | 28 |
| Fixed assets, net | 2 | 2 | 2 | 2 |
| Total assets | 3 | 53 | 7 | 30 |
| Other accounts payables and accrued expenses | 527 | 506 | 475 | 473 |
| Short-term credit from related party | 37 | 34 | 41 | 41 |
| Payable to related party | 1,101 | 946 | 755 | 564 |
| Total current liabilities | 1,665 | 1,486 | 1,271 | 1,078 |
| Common stock, 0.01 par value authorized 50,000,000 shares at march 31, 2026 and december 31, 2025 issued and outstanding 20,176,418 at march 31, 2026 and at december 31, 2025, respectively | 202 | 202 | 196 | 196 |
| Additional paid-in capital | 8,533 | 8,533 | 8,435 | 8,396 |
| Accumulated deficit | -10,397 | -10,168 | -9,895 | -9,640 |
| Total stockholders equity (deficit) | -1,662 | -1,433 | -1,264 | -1,048 |
| Total liabilities and stockholders equity (deficit) | 3 | 53 | 7 | 30 |